Drug Pricing Policy Show Moves Into Next Act With Biopharmas' Suit Against DTC Ad Rule

 
• By Cathy Kelly

Merck, Lilly, Amgen join advertisers in suit against HHS; rule helped Trump administration spotlight industry pricing practices but potential impact has always been unclear.

Courthouse Inscription
HHS authority to require list prices in direct-to-consumer drug ads challenged in lawsuit. • Source: Shutterstock

More from Pricing Debate

More from Market Access